Game-changing data-analytics and strategic intelligence for the cannabis industry.
iphy provides actionable insights and strategic intelligence for leaders in emerging life-science and healthcare markets. We handle the heavy lifting of data processing to unlock holistic insights, enabling our partners to focus on driving change.
Holistic Perspectives
Our data shapes the industry’s future with unrivaled insights into every aspects of the customer journey and supply chain.
Unified Knowledge
We combine isolated datasets into a single powerful source, unlocking a comprehensive unterstanding of the market and its direction.
Beyond Statistics
We go beyond traditional market research methods to uncover the hidden patterns that predict future market dynamics.
We are just at the beginning – we built the most comprehensive real-time data stack available for the German cannabis market. We combine our proprietary data with third-party intelligence, analyze it with industry leading validated statistical models.
Our upcoming reports will provide insights into product trends, funding news, drug developement pipelines, real-word-evidence, regulatory developments, competition, and much more.
Our mission is to empower those who shape the future of life-sciences with exceptional and unparalleled software products that will help make the decisions that will shape a more humane and prosperous future.
Human centered. Tech driven. Impact oriented.
The European cannabis markets are emerging. Unfortunately, there has so far been very little publicly available data on the German cannabis market detailed and timely enough to understand the current state of the market, and enable reasonable predictions of short- and medium-term trends.
This is why we have decided to release a variety of free reports on the state of German medical cannabis market.
